Table 4 Therapy-related complications and acute exacerbations of IPF in LC-IPF patients (n = 34)
Complications | % | AEIPF, No. (%) | Mortality of AEIPF, No. (%) |
|---|---|---|---|
Surgery-related complications (n = 3/4) | 75% | 2/4 (50) | 1/2 (50) |
Respiratory failure | 25% | ||
Pneumonia | 50% | ||
Empyema | 25% | ||
Myocardial infarction | 25% | ||
Radiotherapy-related complications (n = 3/5) | 60% | 2/5 (40) | 0/2 (0) |
Radiation pneumonitis | 33% | ||
Pulmonary infections | 33% | ||
Respiratory failure | 17% | ||
Myocardial infarction | 17% | ||
Radio-chemotherapy-related complications (n = 1/2) | 50% | 0/2 (0) | 0/1 (0) |
Radiation pneumonitis | 50% | ||
Chemotherapy-related complications (n = 10/13) | 77% | 8/13 (61.5) | 5/8 (62.5) |
Pancytopenia | 30% | ||
Pneumonia | 40% | ||
Respiratory failure | 20% | ||
Cardiovascular failure | 25% | ||
Total | 71% | 12/24 (50) | 6/12 (50) |